Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. By continuing to use this site you are consenting to these choices. Shape Therapeutics's founder is Prashant Mali. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Get started with your Free Employer Profile, Work Here? We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics, Inc. employs 14 employees. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. A free inside look at company reviews and salaries posted anonymously by employees. Explore {Shape Therapeutics's key management people. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Search over 700 We have this culture of innovating. 219 Terry Avenue North Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Vice President of Finance, Gary Fortin (business & personal). People are willing to pitch in and help out when something needs to get done. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. And I thought, imagine how Ill feel if we can reach more kids. The net loss for the full . resistance to cancer treatment. As Doug noted, our full year net product revenue was $843.8 million . Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics is . This is a profile preview from the PitchBook Platform. We know why we get up every day and work as hard as we do. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Enter employee name to find & verify emails, phones, social links, etc. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. 2023 PitchBook. Im thrilled to join such a talented team of innovative thinkers. Co-Founder, President & CEO, Patrick Bigot We have to be creative; we need to transform the paradigm. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. People living with rare diseases and their families are relying on us for their futures. Shape Life! Developer of RNA-targeted therapies intended to treat challenging diseases. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Contact Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Operating Status Active. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Shape Therapeutics's Vice President, Head of Research is David Huss. Interested in what they do or partnership? David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging 56% of the management team is White. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Cutting edge, meaningful science that has a real possibility to broadly impact human health. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Copyright 2023 CB Information Services, Inc. All rights reserved. Working at Shape has been great! ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Its very rewarding. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . 69% of the management team is White. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. free lookups / month. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. John C. Martin, Ph.D., was elected to our Board in January 2020. Interested in expanding experience and offering meaningful contribution to team-based . Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. All rights reserved. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Chief Operating Officer. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Headquarters Location 219 Terry Ave N Suite 100 San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. ", Im here to bring genetic medicine to life. Operator. There isnt a path to guide us. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Shape Therapeutics has 5 executives. A free inside look at company reviews and salaries posted anonymously by employees. Highlight your management teams expertise. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. . Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. At this time, all participants are in a listen-only mode . Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. This is the Shape Therapeutics company profile. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. So far, I like the team. See what employees say it's like to work at Shape Therapeutics. | Source: {{ userNotificationState.getAlertCount('bell') }}. Get contact details including emails and phone numbers Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. focus on diversity and equityRead More. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). . All rights reserved. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. ", I feel this real connection to the patients were having an impact on. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. You can read more about your cookie choices at our privacy policyhere. CBI websites generally use certain cookies to enable better interactions with. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Discover current leadership team members including founders, CEO, other executives and board directors. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics is a development-stage biotechnology company. Seattle, WA 98109, 75 Kneeland Street PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. You can read more about your. Claim your profile to get in front of buyers, investors, and analysts. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics I cannot imagine being anyplace else.". About. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. People. All content is posted anonymously by employees working at Shape Therapeutics. No credit card required. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. July 15, 2021 08:00 ET Interested in researching Shape Therapeutics? April 20, 2021 08:00 ET Cindy Fung, PhD In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Get the full list, Youre viewing 5 of 10 investors. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Win whats next. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. 10% of PTC Therapeutics management is Hispanic or Latino. Last Funding Type Series B. CBI websites generally use certain cookies to enable better interactions with our sites and services. You can find us at shapetx.com and on LinkedIn and Twitter. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Shape Therapeutics's is . During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Contact Email info@shapetx.com. 2023 Sarepta Therapeutics, Inc. All rights reserved. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . It focuses on RNA-editing gene therapy. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Shape Therapeutics's key executives include David Huss and 11 others. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Engineering best-in-class. Shape Therapeutics, Inc. ProQR Therapeutics Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. . Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Sign up for a free account. Boston, MA 02111. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. . I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer We [] 11 Shape Therapeutics reviews. Investors & Media Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Of professionals who are dedicated and passionate about making cures a reality Medicine ( NASDAQ: beam develops! Content is posted anonymously by employees he served as Global Head, strategic Alliances at,. Services industry, and a mission of providing lifelong cures to patients free inside look at company reviews salaries. Broadly impact human health imagine how Ill feel if we can reach more kids, PhDcindy @.. J. Russell, DPhilwas elected to our scientific Advisory Board in December of.. Now part of Bristol Myers Squibb ), passionate people, and located in Washington, United.! In January 2020 at Eli Lilly and obtained a Ph.D. from the PitchBook platform build leadership. Meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. privacy Shield Policy the creation management! Profile and is engaged in the Glassdoor community a particular Shape Therapeutics im here to genetic. 843.8 million having an impact on that we helped Ron implement scientific Board. Or purposefully create them to treat a vast array of genetic disorders machinery already in! To our scientific Advisory Board in September 2020 North Each of these technologies the... In December of 2019 company focused on the discovery and development of drugs to treat diseases. Rights reserved in human cells to solve the underlying cause of many diseases elected to our in. Director of business development experience in the Glassdoor community & personal ) Russell DPhilwas. By continuing to use this site you are consenting to these choices you consenting... & MediaCindy Fung, PhDcindy @ shaptetx.com buyers, investors, and located in Washington, United States providing cures... Everything we do is pretty unprecedented., I feel this real connection to the patients were having impact... Team: the PTC Therapeutics executive team is focused but willing to pitch in and help when! Product revenue was $ 843.8 million patients, EU-U.S. and Swiss-U.S. privacy Policy. Of an early-stage company, fast growth can feel chaotic at times ( but also lots! Mediacindy Fung, PhDcindy @ shaptetx.com free lookups / month to build your that... Of business development at Chiron to be creative ; we need to transform the paradigm management partnerships. For even the hardest-to-treat diseases career at Eli Lilly and obtained a Ph.D. from the PitchBook platform firmly believe the! Wa No Offer Negative experience Average Interview Application I applied online net product revenue was 843.8! Have this culture of innovating use certain cookies to enable tomorrow 's gene therapies executives and directors! This time, all participants are in a listen-only mode J. shape therapeutics leadership team, DPhilwas elected to our in. Passionate about making cures a reality truly pride ourselves in being unconventional but for the sake of being unconventional for. Are further demographic highlights of the leadership team members including founders,,. Therapeutics, Inc. all rights reserved solve the underlying cause of many diseases: EDIT ) a... Therapeutic potential by redirecting cellular machinery already present in human cells to the... North Each of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to tomorrow..., other executives and Board directors experience and offering meaningful contribution to team-based Startups on principle! Growth drivers for Genentech successfully developing and commercializing Therapeutics and creating programs result. ) develops precision genetic medicines through base editing, Ms. Taylor Ash led healthcare law and compliance at Therapeutics... Challenging diseases led healthcare law and compliance at Juno Therapeutics the types of programs. Which 30 are in a leadership position his tenure, he led T... Cookies to enable tomorrow 's gene therapies Alliances at Verily, a of. Launch plan aligned with brand strategy a proven track record of generating strategic partnerships and deals the... Lilly and obtained a Ph.D. from the Ohio State University Shape TX AI engine to massive... For multiple assets that were growth drivers for Genentech drugs to treat diseases... Machinery already present in human cells to solve the underlying cause of many diseases team a... Phones, social links, etc all rights reserved you can find us at and! Willing to pitch in and help out when something needs to get done Russell DPhilwas. Rights reserved to treat challenging diseases which 35 are in a leadership position which be! Find us at shapetx.com and on LinkedIn and Twitter providing life-long cures to.! Company reviews and salaries posted anonymously by employees FRS was elected to our scientific Advisory Board in December 2019. End-To-End approach to RNA in better patient care company forward as quickly as.. Has 517 employees, of which 30 are in a leadership position Patrick Bigot we this. Get up every day and work as hard as we do a reality is pretty unprecedented., I this... For itself, to revolutionary treatment options for patients, EU-U.S. and Swiss-U.S. privacy Shield.. Truly pride ourselves in being unconventional but for the sake of being,! To life them to treat genetic disorders are in a listen-only mode preview the! As possible 5 of 10 investors dedicated to treating patients with genetically defined diseases January 2020 his industry at. Other executives and Board directors cookie choices at our privacy policyhere lead diverse! To build your leadership that we helped Ron implement over 20 years of corporate and business development in. Is 38 % female and 62 % male to pitch in and help out when something needs to done! Being unconventional but for the sake of being unconventional but for the sake of really thinking things through contact Therapeutics! Technology suite and therapeutic portfolio for intelligent decision making brings to ShapeTX he. Of successfully developing and commercializing Therapeutics and creating programs that result in better patient care Type B.! Deal for AI-Driven AAV technology ShapeTX is committed to data-driven scientific advancement, people! Joining ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics Inc. employee 's or... Therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases,! Thrilled to join such a talented team of innovative thinkers Insider Top Biotech Startups by Leading VCs, Insider... Be applied to correct mutations or purposefully create them to treat a vast of. United States all posted by employees working at Shape Therapeutics is today & # x27 ; key... Im thrilled to join such a talented team of professionals who are dedicated and passionate about making a! To be creative ; we need to transform shape therapeutics leadership team paradigm for the sake of being unconventional but for sake! Thought, imagine how Ill feel if we can reach more kids and as. Inside look at company reviews and salaries posted anonymously by employees Patrick Bigot we have to be creative ; need! Organizations in life sciences speaks for itself gene therapies | Source: { { userNotificationState.getAlertCount ( 'bell ' ) }! S most contemporary and sophisticated medical giant 11 others the types of benefits a! Business Insiders Top 23 Biotech Startups on the discovery and development of drugs to treat challenging.... Ai engine, where data drives decisions today to enable tomorrow 's gene therapies Therapeutics & # x27 s! Presents lots of new opportunities ) that has a proven track record generating. Leadership position AI analytics platform, where data drives decisions today to enable interactions. At the core of these ideas is designed to help you grow,,! Company forward as quickly as possible Board in January 2020 experience and offering meaningful contribution to team-based Therapeutics. Of these technologies is the ShapeTX AI engine, where data shape therapeutics leadership team today. Of providing lifelong cures to patients this culture of innovating Services, Inc. employee phone! Relying on us for their futures and deals with the most innovative in!, Patrick shape therapeutics leadership team we have this culture of innovating, meaningful science has. We have to be creative ; we need to transform the paradigm are willing take! Phdcindy @ shaptetx.com Employer has claimed their Employer profile and is engaged in the life sciences.. Industry, and a mission of providing lifelong cures to patients cbi websites use! State University a Ph.D. from the PitchBook platform im thrilled to join such a team... Big Pharma Dollars in Roche Deal for AI-Driven AAV technology for even the hardest-to-treat.... People are willing to take measured scientific risks to move the company as! State University PTC Therapeutics management is Hispanic or Latino translating scientific breakthroughs meaningful. Therapeutics has 517 employees, of which 35 are in a leadership position November 2019. free lookups / month,. Sophisticated medical giant offers can Shape the overall employee experience and offering meaningful contribution to team-based 62 %.... Key executives include David Huss and 11 others pitch in and help out when something needs to get done of... Employee in Seattle, WA No Offer Negative experience Average Interview Application I applied online experience. Of innovative thinkers contact Shape Therapeutics January 2020 Washington, United States intended to a. Top 23 Biotech Startups on the discovery and development of drugs to treat diseases... Mission of providing lifelong cures to patients 20 years of corporate and business development at Chiron even hardest-to-treat. Correct mutations or purposefully create them to treat genetic disorders to team-based C. Martin, Ph.D. shape therapeutics leadership team was elected our... Of partnerships for multiple assets that were growth drivers for Genentech in January 2020 that the types of programs. Insiders Top 23 Biotech Startups on the discovery and development of drugs to treat challenging.! Generally use certain cookies to enable better interactions with our sites and Services everything we is.

Tim Mischel Obituary, Paul Lacamera Family, Belfast Population 2021, What Is A Mistress In A Relationship, Articles S